Standout Papers
- Diabetic kidney disease: world wide difference of prevalence and risk factors. (2016)
Immediate Impact
61 standout
Citing Papers
Finerenone with Empagliflozin in Chronic Kidney Disease and Type 2 Diabetes
2025 Standout
Energy metabolism in health and diseases
2025 Standout
Works of Narayanan Nampoory being referenced
Diabetic kidney disease: world wide difference of prevalence and risk factors.
2016 Standout
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Narayanan Nampoory | 161 | 115 | 24 | 142 | 12 | 437 | |
| Yi‐Chih Lin | 156 | 115 | 39 | 131 | 14 | 456 | |
| Dongsheng Cheng | 156 | 139 | 21 | 106 | 21 | 450 | |
| Elizabeth Kern | 139 | 67 | 42 | 88 | 11 | 435 | |
| Jinshan Wu | 129 | 137 | 23 | 140 | 15 | 471 | |
| Brijesh Sutariya | 99 | 164 | 31 | 115 | 21 | 464 | |
| Toshihide Shike | 155 | 116 | 17 | 86 | 15 | 434 | |
| Adeel Ijaz | 185 | 147 | 22 | 68 | 7 | 451 | |
| Ji Eun Lee | 109 | 126 | 18 | 94 | 17 | 493 | |
| Amir Ghorbani Haghjo | 93 | 145 | 32 | 142 | 16 | 498 | |
| Yuan-ye Qiu | 96 | 242 | 14 | 94 | 13 | 494 |
All Works
Loading papers...